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Abstract 
Purpose/Objective(s): MRI provides no ionizing radiation dose (allowing inter and intra fraction 
imaging), improved soft tissue contrast and potentially improved conformity in delineation than 
CT.  This study aimed to determine if T2 weighted magnetic resonance imaging improves 
seroma cavity (SC) and Whole Breast (WB) inter-observer conformity for radiotherapy purposes 
compared with the gold standard of CT, both in the prone and supine positions.  
Methods and Materials: Eleven observers (two Radiologists and nine Radiation Oncologists) 
delineated SC and WB Clinical Target Volumes (CTVs) on T2-weighted MRI and CT supine 
and prone scans (4 scans per patient) for 33 patient datasets. Individual observer’s volumes were 
compared using the Dice Similarity Coefficient (DSC), Volume overlap Index (VOI), Centre of 
Mass (COM) shift and Hausdorff Distances (HD). An average Cavity Visualization Score (CVS) 
was also determined. 
Results: Imaging modality did not affect inter-observer variation for WB CTVs. Prone WB 
CTVs were larger in volume and more conformal than Supine CTVs (on both MRI and CT). SC 
volumes were larger on CT than MRI. SC volumes proved to be comparable in inter-observer 
conformity in both modalities (VOI of 0.57±0.03 for CT supine, 0.52±0.04 for MR supine, 
0.56±0.03 for CT prone and 0.55±0.04 for MR prone) however after registering modalities 
together the inter-modality variation (DSC of 0.41±0.05 for supine and 0.38±0.04 for prone) was 
larger than the inter-observer variability for SC despite the location typically remaining constant.  
Conclusions: MRI inter-observer variation was comparable to CT for the WB CTV and SC 
delineation, in both prone and supine positions. Whilst the CVS and inter-observer concordance 
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was not significantly higher for MRI than CT, the SCs were smaller on MRI, potentially due to 
clearer SC definition, especially on T2-weighted MR images.  
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Introduction 
Approximately 80% of patients with breast cancer should receive radiotherapy [1]. However 
uncertainties in defining the Whole Breast (WB) Clinical Target Volume (CTV) exist and the 
optimal method to define the seroma cavity (SC) remains unclear [2]. Targeting the SC is crucial 
because, if missed, local control rates may be adversely affected [3,4]. Contouring variability of 
the SC has important implications for accelerated partial breast irradiation [5].  
Soft tissues such as the SC walls and postoperative complexes (POCxs) are better visualized on 
MRI and 3D ultrasound (US) compared to CT (which only images the SC fluid [6]). Small 
observer studies have shown conflicting results, with the SCs proven to be both smaller (with 
less inter-observer variation from 3 observers, [7]) and larger (one observer, [8]) on MRI than 
CT. Clips provide another option [9], however these are not always consistent with the SC walls 
[10], can migrate and are larger than CT and US defined volumes [11].  
Inter-observer variation quantification and minimization for the WB is necessary, as techniques 
improve and set-up uncertainties are reduced (such as Deep Inspiration Breath Hold (DIBH)  
[12]).  Studies with a limited number of observers comparing WB CTV for MRI and CT have 
shown no difference in delineation variations [13],[14]. One study showed larger MRI volumes 
than CT [13], the other showed CT to be larger than volumes optimised on registered MRI/CT 
(initially delineated on CT) [14]. 
Breast MRIs for diagnostic purposes are undertaken in a prone position with MRI coils designed 
to achieve optimum signal-to-noise ratio (SNR) in this position. CT is the current standard of 
care for delineation of radiotherapy breast volumes, however MRI is the preferred modality for 
diagnostic purposes [15]. Despite earlier work demonstrating challenges with supine MRI [15] 
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recent investigations have demonstrated feasibility [16]. MRI is non-ionizing, unlike CT, and 
could enable additional imaging throughout the patients treatment in future, to improve accuracy 
without exposing the patient to further ionising radiation. This study has undertaken a larger 
inter-observer variation study for whole breast CTV and SC radiotherapy delineations for CT 
and MRI in both prone and supine positions. 
 
Materials and Methods 
Cohort of patients  
Following ethics approval 33 breast cancer patients receiving adjuvant breast radiotherapy were 
recruited from July 2012 to November 2014. Patients were above 18 years, had undergone breast 
conservation surgery, and been recommended adjuvant breast radiotherapy. Patients were 
excluded if they had a contraindication for MRI.  Patient characteristics are displayed in Table 1. 
Imaging  
Patients underwent scans in two positions; 1) supine with a vacbag on a flat wing board 
(MTWB09 Wingboard, CIVCO Medical Solutions, Orange City, IA) with arms raised above 
their head, and 2) prone position, with the MRI coil housing as a set-up device to ensure 
consistent set-up between CT and MRI. CT scans were undertaken on a Philips CT scanner with 
2 mm slice thickness and 1.024 px/mm resolution, wires were placed around the breast tissue for 
supine CT for clinical purposes. MRIs were undertaken on a 70 cm bore MAGNETOM Skyra 3 
T (Siemens Medical Systems, Erlangen, Germany) scanner with a 3 T non-contrast T2 weighted 
turbo spin echo with 2 mm slices and no slice gap, no fat suppression, acquisition scan time of 
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2.9-7.4 minutes (this does not include patient set-up time), TE of 76-88 ms, TR of 2430-12360 
ms, flip angle of 120-180o and pixel bandwidth of 220-450 Hz/pixel. The prone MRI was taken 
using a dedicated 16 channel breast coil (Sentinelle Breast MRI System, Hologic Inc, Bedford, 
USA) with 1.318 px/mm resolution. The supine MRI was acquired with 18 channel surface coils 
held close to but not touching the breast tissue (to avoid deformation of the breast) utilizing a 
foam bridge, with 1.707 px/mm resolution. MRIs were completed within 14 days of the CT scans 
for all patients except 1 (17 days) and was performed on the same day for 26 patients. 
The T2 sequence was selected based on a previous study on a separate cohort of volunteers [17]. 
The selected T2 sequence is also supported in the literature for visualizing SCs [18].  
Image-processing 
 The wires on the CT Supine image set were removed by post processing in MILXview 
(Australian e-Health Research Centre (AEHRC), Australia). Images were imported into 
Treatment Planning Systems (TPSs) at the four hospitals of the observers, including Pinnacle3 
versions 9.0 and 9.8 (Philips, Netherlands) at two sites and Eclipse Planning System 11.0.64 
(Varian Medical Systems, Palo Alto USA) at two sites.  
Delineation method  
A study-specific delineation protocol was utilized by all observers (9 radiation oncologists and 2 
radiologists) for the WB CTV and SC (supplementary Material 1). This protocol was edited after 
a single complete patient dataset had been contoured by all participants and the anonymized 
volumes reviewed together.  
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Contouring was undertaken in batches of 8-20 datasets with images from only a single-modality 
(CT or MRI) for each position (prone or supine) included in each batch to avoid recall of 
individual patient data. The order in which the 4 image datasets were circulated for each patient 
was varied. Observers were blinded to others contours. Patient notes or other information on SC 
location were not available to the clinicians, to ensure that the study tested the utility of the 
images alone. If no SC was able to be visualized then no SC was contoured.  
Cavity Visualization Score (CVS) 
 CVSs adopted from [19-21] for each image were established by two radiation oncologists (at 
least 4 months post the last delineation) and one radiation therapist (RT), utilizing the images 
alone, at the same window levels as for contouring.  
Analysis 
Review of the SCs showed that some observers had contoured axillary Lymph Node (LN) cavity 
rather than the SC, although the protocol specified contouring of the SC. Thus for the generation 
of the SC gold standard volumes only 17 patients and 8 observer SCs were utilized to rule out the 
effects of unidentified SC or contours of the axillary Lymph Node (LN) SC. The combination of 
17 patients and 8 observers were selected to retain large numbers of both observers and patients, 
with SC contours on all 4 datasets. Observers excluded were not less experienced however were 
more frequent in contouring the axillary Lymph Node (LN) SC or not visualizing a SC. Gold 
standard WB CTV and SC volumes were generated, to aid visual comparison of modalities, 
using the Simultaneous Truth And Performance Level Estimation (STAPLE) algorithm [22] for 
each dataset. All observers were weighted equallyin the STAPLE generation. The STAPLE, 
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generalised kappa statistic (κ) [23,24] and volume were calculated utilizing CERR (a 
computational environment for radiotherapy research) software [25] in the MATLAB R2012a 
(Mathworks Incorporated, Natick USA) platform, with a subset of metrics verified in MILXview 
to agree to within 2 significant figures, similarly to other reported values [26].  Generalized 
kappa (κ) statistics determine inter-observer delineation agreement which occurs by chance 
alone. Generalised kappa (κ) values (where +1  represents perfect agreement,  0  represents no 
agreement above chance and −1  represents complete disagreement) were generated for each of 
the patients WB and SC volumes.. Pairwise analysis, such as the Volume Overlap Index (VOI) 
which is the Dissimilarity Index (DSC) performed pairwise [27,28], was completed in 
MILXview. The average of all three observers’ CVSs were compared to contour conformity. 
MRI datasets were rigidly registered to the corresponding CT by a Radiation Therapist (RT) in 
Pinnacle using the ‘normalized mutual information algorithm’ within a region of interest which 
included the breast of interest, sternum, chest-wall muscles and ribs. Difficult cases were verified 
by a separate experienced RT. MRI volumes were transferred onto the CT dataset for 
comparison of individual observer volumes between MRI and CT using DSC, COM shift, and 
Hausdorff Distance (HD) (in MILXview). These were then averaged over observers and patients. 
The impact of MRI geometric systematic distortion on the patient MRIs was assessed in a related 
study and found to be minimal [29,30]. 
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Results 
Whole Breast CTV 
Both CT and MRI supine WB CTVs were smaller in volume than the corresponding prone 
volumes (p<0.001), with MRI supine volumes smaller than all other datasets (p<0.001) (Fig 1a).  
High inter-observer agreement was seen for WB CTV for all metrics across observers (Fig. 1b) 
and across datasets (Table 2). Prone datasets had slightly higher inter-observer conformity than 
supine for both modalities (p<0.001 for VOI (DSCpairwise), and κ).  The average CT supine HDs 
are lower than all other datasets CTVs (p<0.001). 
Average concordance for registered datasets was comparable to the inter-observer concordance 
(Fig. 1(b) and Table 3).   
SC volumes 
There was obvious disagreement between SC volumes particularly where some observers 
delineated a volume and others did not.. In total 120 SC volumes out of the potential 1452 (11 
observers on 4 modalities for 33 patients) were not delineated. Of these 26/120 were on CT 
supine, 33/120 on MRI supine, 32/120 on CT prone and 29/120 on MRI prone. There was no 
discernible correlation between the omitted SC volumes, in terms of modality, nor position. Only 
4/33 patients had their SC volume delineated by all observers, and only 3/11 observers contoured 
SC volumes for all patients. For the majority of patients where the SC volumes were not 
delineated by at least 1 observer on at least 1 of the 4 datasets (CT supine, CT prone, MRI supine 
and MRI prone), delineations were drawn on some datasets but not others. The SC volume was 
compared across datasets in Table 2.  
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The inter-observer SC volume agreement was lower than the WB CTV agreement. The SC 
volumes were of moderate inter-observer agreement (κ between  0.41-0.6 [23]) for all datasets. 
There was no statistical difference between any datasets for κ or the COM shift. The average 
HDs were slightly larger for CT than MRI in prone position (p<0.05).  
Variation between modalities and across observers was small (Fig 1b); however variation 
between patients was large (Fig 2). The registration conformity (DSC) for MRI to CT SC 
volumes (Table 3) was lower than inter-observer conformity. The majority of MRI SC volumes 
were smaller than the corresponding patients CT SC volume. The relatively low registered DSC 
was due to these volume differences between MRI and CT SC volumes. One patient had a DSC 
of zero due to different SC locations, patient number 27 (Fig. 2). There are small average COM 
shifts between modality contours (for supine=1.13±0.19 cm and prone=1.16±0.16 cm). These 
registration COM shifts are slightly larger than the inter-observer COM shift within datasets 
(0.74±0.11 cm for CT supine, 0.81±0.16 for MRI supine, 0.78±0.12 for CT prone and 0.72±0.16 
cm for MRI prone), as shown in Fig. 2(b).  
The 8 volumes on CT and MRI and the registered gold standard STAPLE volumes are shown for 
differing CVSs in supplementary material 2. The CVS was highly correlated with conformity 
measures, as shown in Supplementary Material 3. 
 
 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
11 
 
Discussion 
WB CTV inter-observer variability was consistently smaller on the prone datasets than the 
supine (p<0.001 for both MRI and CT metrics: VOI and κ). It has been well established that the 
main contouring discrepancies are at the medial and lateral edges of the WB CTV in supine 
imaging [31,32], however in prone datasets, geometrically these areas are reduced. Both intra-
observer delineation variations [33] and differences due to planning system and data transfer [26] 
are much smaller than inter-observer variation and thus expected to have minimal impact on 
these WB results.   
Importantly no clinically significant differences were seen in inter-observer or inter-modality 
variability between the prone and supine MRI datasets, demonstrating that supine MRI for the 
purpose of radiotherapy contouring can be considered equivalent to prone MRI, despite the 
differences in coils and positioning. This is different to the diagnostic setting where supine breast 
MRI is not standard. 
Inter-observer variability when delineating the SC was not highly concordant e.g. CT supine 
average VOI of 0.57. There are many factors that may influence inter-observer seroma 
delineation. For some patients, there may be several cycles occurring between lumpectomy and 
imaging for radiotherapy, resulting in the SC volume no longer being able to be visualized [18].  
In this study any correlation between the lengths of time post-surgery or the presence of 
chemotherapy, and the CVS was not able to be differentiated, due to multiple factors obscuring 
any correlation.  These factors include differences across individuals including size of tumor, 
size of cavity, surgeon, and post-op bleeding or infection. Registration uncertainties also affect 
CT-MRI registered results. 
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The ~1.1 cm COM shift (and low DSC of ~0.4) between CT and MRI modalities may be of 
concern clinically for APBI and boost treatments. Adding this large uncertainty into the 
treatment margins may adversely affect normal tissue, furthermore if you are only treating the 
cavity for APBI the risk of geographic miss increases. However, this would not be the case for 
intraoperative radiation therapy (IORT) including APBI and boost treatments.  
The closeness of the various inter-observer variability scores suggests MRI does not offer any 
advantages over CT in determining the WB CTV. However the impact of differences in SCs 
(which may impact on whole breast treatment planning as well as partial breast approaches) 
between CT and MRI warrant further investigation. MRI SC volumes (average of 22 cm3) were 
smaller than CT SC volumes (average of 28 cm3) in both positions. This result was similar to 
another study of 15 prone patients where this volume difference indicated superior delineation on 
MRI [34].  MRIs were performed without a contrast injection because SC volumes are well-
visualized on non-contrast enhanced T2-weighted images and post-surgery, ideally no tumor 
remains to take up contrast to aid localization.  
Limitations of this study include; some observers not being as experienced with MRI as they are 
with CT, the relatively small cohort size, especially the smaller subset included in the SC 
analysis, the fact that surgical clips were not mandatory nor excluded giving a small subset of 
8/17 patients with surgical clips. The clips were titanium and are evident on both CT, shown 
clearly as a bright white marker and MRI as a black artifact. In order to test the use of the 
imaging modalities ability to determine seroma location and volume in isolation, no clinical 
history or localisation information (such as ultrasound location of tumour) were provided. This is 
therefore an artificial situation compared to clinical practice where this information (as well as 
surgical clips) are routinely provided. Consequently the identification of the SC volume is 
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image-based and different to the true surgical volume utilised clinically, similarly to other studies 
that volumed the postoperative complex [6]. The interobserver concordance (VOI) for the 
patients with (≥4 clips) and without clips denoting SC boundaries was in agreement for all 
datasets except CT supine, where average conformity for those without clips was higher. This 
may be because clips are not always consistent with the SC walls [10], can migrate significantly 
over days/weeks postoperatively [35] and are larger than CT and US defined volumes [11]. 
Registered CT/MRI delineation has not been evaluated here, as the primary goal was to evaluate 
MRI delineation alone, to assess any benefit or equivalence towards MRI only planning. 
 
 
Conclusion 
MRI inter-observer variation was considered for 33 patient datasets and 11 observers and found 
to be comparable to CT for the WB CTV in both prone and supine positions. For the SC, the 
dataset was reduced due to inconsistency in contoured volumes. Whilst the SC inter-observer 
concordance was not significantly higher for MRI than CT, the SCs were smaller on MRI, 
potentially due to clearer SC definition on non-contrast enhanced T2 weighted MRI.  
Concordance between individual MRI-CT registered observer volumes was lower than inter-
observer concordance for the SC volumes and comparable for the WB. Further investigations, 
with increased patient numbers, into the impact of the differences in SCs from CT to MRI are 
required.  
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Figure Legends 
Fig. 1. Average WB (33 patients with 11 observers) and SC (17 patients with 8 observers) 
inter-observer comparison for: a) Volume b) DSCpairwise (VOI) within datasets and average 
DSC for CT-MRI registered datasets.  
Fig. 2. The average SC inter-observer and registration variation from eight observers for; 
a) DSCpairwise (inter-observer) and DSC(registration), and b) the COM shiftpairwise (cm), 
across the 17 patients. 
Table Legends 
Table 1. Patient characteristics with 4 image-sets MR-supine (MRs), CT-supine (CTs), MR-
prone (MRp) and CT-prone (CTp). 
 
Table 2. Average metrics for 4 independent datasets for WB (33 patients and 11 observers) 
and SC volumes (17 patients and 8 observers) with 95% Confidence Intervals.  
Table 3. Average for both WB CTV and SC volumes of each observers contour on CT 
compared to their contour on MRI for various metrics with 95% Confidence Intervals. 
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Table 1. Patient characteristics with 4 image-sets MR-supine (MRs), CT-supine (CTs), MR-prone (MRp) 
and CT-prone (CTp). 
  No. of patients- WB No. of patients- SC 
Total No. of patients  33  17  
Laterality    Left 
Right 
15 
18 
5 
12 
Topography UOQ 
UIQ 
LIQ 
LOQ 
Central Portion 
Unspecified 
Intraductal (CIS) 
Overlapping 
13 
9 
1 
2 
2 
3 
2 
1 
5 
6 
0 
2 
2 
1 
1 
0 
Age in years Median (Range)  59 (38-72) 62 (41-72) 
T-stage T1b 
T1c 
T2 
Tis (DCIS) 
8 
17 
6 
2 
6 
6 
4 
1 
Axillary lymph node 
status/N-stage 
 
N0 
N1 
N1a 
N3a 
26 
3 
3 
1 
15 
0 
1 
1 
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NX 1 0 
Receive neoadjuvant 
chemotherapy 
Yes 
No 
13 
20 
7 
10 
Stage IA 
IIA 
IB 
IIIC 
0 (Tis (DCIS)) 
21 
10 
1 
1 
2 
11 
4 
0 
1 
1 
No. of patients that had 
surgical clips  
4-6 clips 
1-2 surgical staples 
None 
14 
6 
13 
8 
6 
3 
Time between surgery and 
Computed Tomography 
< 1 month 
1-2 months 
2-3 months 
3-4 months 
4-5 months 
6-7 months 
2 
14 
4 
5 
6 
2 
2 
5 
2 
3 
5 
0 
Cavity Visualisation Score 
category (averaged over 
all 4 datasets and 3 
observers) 
5(CTs/MRs/CTp/MRp) 
4(CTs/MRs/CTp/MRp) 
3(CTs/MRs/CTp/MRp) 
2(CTs/MRs/CTp/MRp) 
1(CTs/MRs/CTp/MRp) 
2/5/2/5 
7/5/5/6 
14/7/16/10 
9/15/10/12 
1/1/0/0 
2/5/2/4 
4/3/4/4 
8/3/7/5 
3/6/4/4 
0/0/0/0 
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Table 2. Average gold standard and pairwise metrics for 4 independent datasets for WB (33 patients 
and 11 observers) and SC volumes (17 patients and 8 observers) with 95% Confidence Intervals.  
 CT SUPINE MRI SUPINE CT PRONE MRI PRONE 
WB     
Volume (cm
3
) 675±32 658±33 785±38 778±40 
VOI (DSC pairwise) 0.839±0.005 0.840±0.004 0.867±0.004 0.868±0.004 
Kappa 0.81±0.01 0.81±0.01 0.84±0.01 0.84±0.01 
HD pairwise (cm) 2.78±0.06 3.07±0.07 3.16±0.08 3.09±0.08 
AV COM shift pairwise (cm) 0.53±0.02 0.67±0.03 0.54±0.02 0.54±0.02 
SC     
Volume (cm3) 27±6 20±6 28±6 21±6 
VOI (DSC pairwise) 0.57±0.03 0.52±0.04 0.56±0.03 0.55±0.04 
Kappa 0.53±0.09 0.47±0.12 0.52±0.09 0.49±0.13 
HD pairwise (cm) 1.8±0.1 1.6±0.2 1.9±0.3 1.6±0.5 
AV COM shift pairwise (cm) 0.74±0.11 0.81±0.16 0.78±0.12 0.72±0.16 
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Table 3. Average for both WB CTV and SC volumes of each observers contour on CT compared to their 
contour on MRI for various metrics with 95% Confidence Intervals. 
 Supine Registration (MRI to CT) Prone Registration (MRI to CT) 
WB   
DSC 0.853±0.005 0.851±0.005 
HD (cm) 2.7±0.2 3.0±0.1 
COM shift (cm) 0.87±0.15 0.88±0.16 
SC   
DSC 0.41±0.05 0.38±0.04 
HD (cm) 2.1±0.2 2.2±0.2 
COM shift (cm) 1.13±0.19 1.16±0.16  
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Summary 
Inter-observer variation and volume differences in seroma cavity (SC) and Whole Breast (WB) 
Clinical Target Volumes (CTVs) from MRI and CT images, in prone and supine positions, were 
compared. Prone WB CTVs were larger and exhibited less inter-observer variation than supine in 
both imaging modalities. CT SC volumes were significantly larger than MRI in both positions. 
No clinically significant differences in inter-observer variation were demonstrated between MRI 
and CT for WB or SC volumes. 
 
